American Cancer Society's Chief Medical Officer to participate in roundtable on prostate cancer screening.
A leading US cancer control expert, Dr Otis Brawley, is visiting Cancer Council Victoria where he will discuss policy development for prostate cancer screening with its Director, Professor David Hill AO.
The Chief Medical Officer and Executive Vice President of the American Cancer Society, Otis Brawley, MD, is also an acknowledged global leader in the field of health disparities research and is listed as one of America's ‘Top Doctors for Cancer' by Castle Connolly Medical Ltd, a healthcare research and information company that helps consumers find America's top doctors and top hospitals.
"The issue of using prostate specific antigen tests (PSAs) as a prostate cancer screening tool is a hot topic here in Australia and overseas; Dr Brawley shares the Cancer Council's position that PSA testing should not be used as a population screening tool for prostate cancer," Professor Hill said. "I'm interested in discussing this issue in light of recent research and ongoing media scrutiny. However, I'm also interested in finding out about the American Cancer Society's research, prevention and early detection programs."
During his visit to Melbourne, Dr Brawley will:
- present on ‘Screening complexities: the contribution and potential of behavioural research in improving cancer screening outcomes' to members of the Cancer Council's Victorian Cooperative Oncology Group* (VCOG), epidemiology and behavioural research staff from Cancer Council Victoria and representatives of the state's integrated cancer services, and
- participate in a roundtable discussion on prostate cancer screening with cancer clinicians, and present ‘Prostate Screening - looking at the evidence and outcomes' to Cancer Council Victoria's Victorian Cooperative Oncology Group (*VCOG).
"I'm looking forward to my discussions with Professor Hill - both as Director of Cancer Council Victoria and as President of the UICC (International Union Against Cancer) - and to the roundtable discussion on prostate cancer screening.
"Professor Hill and the organisations he represents have excellent reputations as leaders in prevention programs and behavioural research, so I'm hoping this opportunity will result in information sharing that will benefit us and our respective organisations.
"I imagine the roundtable discussion will be quite interesting and always welcome having discussions with experienced clinicians to hear their experiences and perspectives," Dr Brawley said.
Following Dr Brawley's visit to Melbourne, he will present at Cancer Council Western Australia's 10th Behavioural Research in Cancer Control (BRCC) Conference in Perth in mid-April.
*VCOG is the peak multi-specialty representative oncology forum in Victoria. The aim of VCOG is to advise the Cancer Council on all clinical aspects of cancer and in particular, on research, prevention, screening, diagnosis, treatment, palliative medicine and professional education.